Brianna Hoffner, MSN, NP, RN, discusses complex immune-related adverse events and how nurses can go about treating patients.
At the 2016 SITC Annual Meeting, Brianna Hoffner, MSN, NP, RN, from the University of Colorado Cancer Center discusses complex immune-related adverse events and the considerations that should go in to treating them.
In the example Hoffner uses, the cause of the patient’s symptoms must be parsed out, to discover which are the result of the immunotherapy agents. In this case, further diagnostic imaging provided the answer—that the patient was experiencing both pneumonitis and colitis concurrently.
Pembrolizumab in Addition to Cisplatin and Gemcitabine Boosts Overall Survival in Advanced Biliary Tract CancerApril 20th 2023
Patients who received pembrolizumab plus cisplatin and gemcitabine achieved a median overall survival of 12.7 months, compared with 10.9 months with cisplatin and gemcitabine alone.
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis
Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries
Telephone and Web-Based Program Elicits Clinically Meaningful Results in Breast Cancer Survivors
Luspatercept Elicits High Transfusion Independence Rates in Lower-Risk MDS
2 Clarke Drive
Cranbury, NJ 08512